Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Bibliographic Details
Main Authors: Iqbal, Nayyar, Allen, Elsie, Öhman, Peter
Format: Online
Language:English
Published: Dove Medical Press 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158996/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158996/

Similar Items